It looks like you're using an ad blocker.

To enjoy our content, please include The Japan Times on your ad-blocker's list of approved sites.

Thank you for supporting our journalism.

  • HOME DELIVERY |
  • SUBSCRIBE |
  • Login
  • My Account
TODAY'S PRINT EDITION

The Japan Times The Japan Times

medicine

  • Login
  • SUBSCRIBE
  • My Account
  • HOME DELIVERY ≫
  • (FREE ARTICLE)
  • MENU
  • Search
  • News
  • Opinion
  • Life
  • Community
  • Culture
  • Sports
  • City Guide
  • Support
  • Search
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
Japan’s drug regulator considers sweeping changes after COVID-19 vaccine delay

National | FOCUS Dec 2, 2021

Japan’s drug regulator considers sweeping changes after COVID-19 vaccine delay

by Osamu Tsukimori

After being one of the last major developed nations to approve Pfizer's vaccine, Japan's drug regulator is looking to ease approval requirements for future pandemics.

What’s worst about omicron so far is the uncertainty

Commentary / World Dec 1, 2021

What’s worst about omicron so far is the uncertainty

by Andreas Kluth

How should the world respond to omicron? We just have to wait as there is information that we don’t yet have. And for many, the waiting itself is the problem.

Omicron is the price we pay for vaccine inequality

Commentary / World Nov 30, 2021

Omicron is the price we pay for vaccine inequality

by Brad Glosserman

Amsterdam's main airport went into lockdown recently after 61 passengers on two flights from southern Africa tested positive for the new virus. Japan, Hong Kong and Israel have also reported cases.

Japanese drugmaker Shionogi considers developing vaccine for omicron variant

National / Science & Health Nov 30, 2021

Japanese drugmaker Shionogi considers developing vaccine for omicron variant

The company is currently conducting a final clinical trial of its COVID-19 vaccine, aiming to make it available in March.

COVID-19 has changed socialized medicine in Britain forever

Commentary / World Nov 29, 2021

COVID-19 has changed socialized medicine in Britain forever

by Therese Raphael

How did the U.K. make it through the past 20 months of COVID-19? The private sector’s role in delivering publicly funded care needs to be acknowledged.

Moderna says new vaccine for omicron may be ready in early 2022

World / Science & Health Nov 28, 2021

Moderna says new vaccine for omicron may be ready in early 2022

Moderna's chief medical officer says the company should know about the ability of the current vaccine to provide protection in the next couple of weeks.

Can vaccines get rid of long COVID?

Commentary / World Nov 28, 2021

Can vaccines get rid of long COVID?

by Therese Raphael and Sam Fazeli

The subject of long COVID has also been divisive, with social media full of both support groups and skeptics.

Merck says its antiviral pill is less effective in final analysis

World Nov 27, 2021

Merck says its antiviral pill is less effective in final analysis

by Rebecca Robbins

A final analysis of a clinical trial said the antiviral pill reduced the risk of hospitalization and death among high-risk COVID patients by 30%, down from an earlier estimate of 50%.

Did AstraZeneca keep Britain safer from COVID-19 than Europe?

Commentary / World Nov 26, 2021

Did AstraZeneca keep Britain safer from COVID-19 than Europe?

by Therese Raphael

It's suggested that Britain’s home-grown jab may be the reason the country is faring better with the latest COVID-19 wave than Europe. Still, is there evidence for that?

Mass COVID-19 testing: Does it save lives?

Commentary / World Nov 24, 2021

Mass COVID-19 testing: Does it save lives?

by Edo Naito

Would Japan have seen far greater fatalities if it opted for mass COVID-19 testing like other countries rather than just targeting vulnerable group as it did?

Health ministry to allow faster approval of drugs and vaccines in emergencies

National / Science & Health Nov 18, 2021

Health ministry to allow faster approval of drugs and vaccines in emergencies

The plan, to be finalized by the end of the year, comes amid criticism that Japan lagged other countries in approving drugs and vaccines to deal with the COVID-19 pandemic.

Pfizer to allow generic versions of its COVID-19 pill in 95 countries

World / Science & Health Nov 16, 2021

Pfizer to allow generic versions of its COVID-19 pill in 95 countries

by Emma Farge and Michael Erman

A Pfizer executive said last week the market for the drug might be up to 150 million people and that many countries might also be interested in buying doses for their strategic reserves.

« 1 … 21 22 23 … 46 »
  • WHAT’S TRENDING
  • EDITORS’ PICKS
  • Nadeshiko Japan downs Costa Rica to move into knockout stage

    Thumbnail image
  • AI is rewriting the rules of $200 billion games industry

    Thumbnail image
  • Indonesia rides EV rush to domestic IPO boom

    Thumbnail image
  • 'Japan's Anatolia' becomes a home away from home for Kurds and Turks

    Thumbnail image
  • From 'Young General' to 'Supreme Leader': The evolution of Kim Jong Un

    Thumbnail image

PODCAST

  • DEEP DIVE

    A tale of two Fujis: Bullet climbs, crowds and Lizzo

Return to The Japan Times top page
JT Digital Archives The Japan Times Alpha JT Bookclub The Japan Times Jobs Education in Japan
  • SUBSCRIBE
  • NEWSLETTERS
  • ePaper Edition
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
  • About us
  • Contact us
  • Work with us
  • Privacy Policy
  • Link policy
  • Republishing
  • FAQs
  • Announcements
  • Press
  • Sitemap
  • Advertise

The Japan Times LTD. All rights reserved.

The Japan Times